Maintenance rituximab or observation after frontline treatment with bendamustine‐rituximab for follicular lymphomaBrian T. Hill, Brad S. Kahl, James R. Cerhan et al.|British Journal of Haematology|2018Cited by 51
Outcomes of Follicular Lymphoma Patients Treated with Frontline Bendamustine and Rituximab: Impact of Histologic Grade and Early Progression on Overall SurvivalAllison Winter, Brian T. Hill, Loretta J. Nastoupil et al.|Blood|2018Cited by 10